Introduction:
	Preeclampsia is a multisystemic hypertensive disease characterized by endothelial dysfunction and inmunologic dysregulation1. It affects 3-8% of all pregnancies and is involved in 36% of cerebrovascular disease (CVD) during this period2.

Objetive: 
	To describe clinical presentation of CVD in patients with preeclampsia, determine the unfavorable outcome factors and evaluate final disablity. 

Methods: 
	We included patients with preeclampsia and diagnosis of ischemic stroke (IS), intracerebral hemorrhage (ICH) or cerebral venous thrombosis (CVT) from January 1987 to June 2017 in a third care center. Descriptive statistics was used. The primary outcome was final disability by modified Rankin scale (mRs). Significance was defined as p<0,05 and also expressed as odds ratios (OR) and the 95% confidence interval (CI).

Results: 
	We included 61 patients with a mean age of 31,1 years (SD 11). CVT was the most common clinical presentation of CVD in preecalmpsia (n= 28, 46%) (Figure 1). Mean follow-up was 64 months (SD 7,5 months). No additional cardiovascular risk factor was associated for unfavorable outcome in CVD. Favorable outcome (mRs 0-2) at end of follow-up was found in 43 (69%) of patients (Figure 2).

Conclusion:
	Contrary to what Anglo-Saxon literature have reported where ICH is the most common clinical presentation of CVD in preeclampsia (47%)1, we had found more frequency of CVT and there was no risk factor with statistical significance association to unfavorable outcome. The value of our study lies in the condition of a group of patients in fertile and productive stage, and the recent finding of the perdurability of cardio-cerebrovascular risk beyond this period1 should make us consider the need for future studies to assess the risk of recurrence.

CEREBROVASCULAR COMPLICATIONS ASSOCIATED TO PREECLAMPSIA. RISK FACTORS AND FUNCTIONAL OUTCOME